EPIQ Partners’s Fate Therapeutics FATE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
2024
Q3
$36.3K Buy
2024
Q2
Sell
2024
Q1
$73.9K Hold
2023
Q4
$37.7K Buy
2023
Q3
Sell
2023
Q2
$47.9K Buy
2023
Q1
Sell
2022
Q4
$722K Sell
2022
Q3
$1.63M Buy
2022
Q2
$1.71M Buy
2022
Q1
$2.24M Buy
2021
Q4
$2.84M Sell
2021
Q3
$2.9M Sell
2021
Q2
$4.31M Buy
2021
Q1
$3.85M Buy
2020
Q4
$3.95M Buy
2020
Q3
$1.7M Buy